A Study Of Electroconvulsive Therapy In Right Unilateral

Overview

About this study

The purpose of this study is to compare the degree of cognitive side effects (memory impairment, attention, and processing speed) between patients receiving RUL ECT versus BT ECT across the acute treatment course.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years or older

  • Referred for a course of ECT (RUL or BT) as part of standard clinical care by a Mayo Clinic psychiatrist

  • Primary psychiatric diagnosis of major depressive episode (unipolar or bipolar), treatment-resistant depression, or another condition for which ECT is clinically indicated

  • Able to provide written informed consent

  • Able to complete neuropsychological assessments in English or with an approved interpreter

 

Exclusion Criteria:

  • Age under 18 years

  • Pre-existing neurocognitive disorder (dementia, moderate-to-severe traumatic brain injury) that would confound cognitive assessment

  • Lack of capacity to provide informed consent at the time of enrollment

  • Active neurological condition that independently impairs cognition (e.g., active delirium, acute stroke within past 3 months)

  • Maintenance ECT (patients undergoing a continuation/maintenance ECT phase rather than an acute index course)

  • Inability to complete neuropsychological testing due to sensory or motor impairment

 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 008/03/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Brandan Penaluna, M.D., M.B.A.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions